Anti-ATG9B monoclonal antibody

Pre-made anti-ATG9B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ATG9B/ATG9B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0379-Ab-1/ GM-Tg-hg-IP0379-Ab-2Anti-Human ATG9B monoclonal antibodyHuman
GM-Tg-rg-IP0379-Ab-1/ GM-Tg-rg-IP0379-Ab-2Anti-Rat ATG9B monoclonal antibodyRat
GM-Tg-mg-IP0379-Ab-1/ GM-Tg-mg-IP0379-Ab-2Anti-Mouse ATG9B monoclonal antibodyMouse
GM-Tg-cynog-IP0379-Ab-1/ GM-Tg-cynog-IP0379-Ab-2Anti-Cynomolgus/ Rhesus macaque ATG9B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0379-Ab-1/ GM-Tg-felg-IP0379-Ab-2Anti-Feline ATG9B monoclonal antibodyFeline
GM-Tg-cang-IP0379-Ab-1/ GM-Tg-cang-IP0379-Ab-2Anti-Canine ATG9B monoclonal antibodyCanine
GM-Tg-bovg-IP0379-Ab-1/ GM-Tg-bovg-IP0379-Ab-2Anti-Bovine ATG9B monoclonal antibodyBovine
GM-Tg-equg-IP0379-Ab-1/ GM-Tg-equg-IP0379-Ab-2Anti-Equine ATG9B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0379-Ab-1/ GM-Tg-hg-IP0379-Ab-2; GM-Tg-rg-IP0379-Ab-1/ GM-Tg-rg-IP0379-Ab-2;
GM-Tg-mg-IP0379-Ab-1/ GM-Tg-mg-IP0379-Ab-2; GM-Tg-cynog-IP0379-Ab-1/ GM-Tg-cynog-IP0379-Ab-2;
GM-Tg-felg-IP0379-Ab-1/ GM-Tg-felg-IP0379-Ab-2; GM-Tg-cang-IP0379-Ab-1/ GM-Tg-cang-IP0379-Ab-2;
GM-Tg-bovg-IP0379-Ab-1/ GM-Tg-bovg-IP0379-Ab-2; GM-Tg-equg-IP0379-Ab-1/ GM-Tg-equg-IP0379-Ab-2
Products NameAnti-ATG9B monoclonal antibody
Formatmab
Target NameATG9B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ATG9B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0379-Ag-1Recombinant multi-species ATG9B/ APG9L2/ NOS3AS protein
    ORF Viral VectorpGMLV000336human ATG9B Lentivirus plasmid
    ORF Viral VectorpGMLV000490human ATG9B Lentivirus plasmid
    ORF Viral VectorvGMLV000490human ATG9B Lentivirus particle
    ORF Viral VectorvGMLV000336human ATG9B Lentivirus particle


    Target information

    Target IDGM-IP0379
    Target NameATG9B
    Gene ID285973,213948,499973,714284,482799,101096716,506862,100064027
    Gene Symbol and SynonymsApg912,APG9L2,Apgdc2,ATG9B,eONE,Gm574,NOS3AS,RGD1560887,SONE
    Uniprot AccessionQ674R7
    Uniprot Entry NameATG9B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000181652
    Target ClassificationN/A

    The target: ATG9B, gene name: ATG9B, also named as APG9L2, NOS3AS, SONE. This gene functions in the regulation of autophagy, a lysosomal degradation pathway. This gene also functions as an antisense transcript in the posttranscriptional regulation of the endothelial nitric oxide synthase 3 gene, which has 3' overlap with this gene on the opposite strand. Mutations in this gene and disruption of the autophagy process have been associated with multiple cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.